NEW Study. “Pharmacies in the most ethnically segregated and economically deprived counties had 2.66X the odds of restricting buprenorphine dispensing, compared to pharmacies in the most privileged counties after adjustment.“ sciencedirect.com/science/articl… #Pharmacoequity 💊

1/💡🚨📰 *NEW in AAP Pediatrics* We used national supply data to analyze >15mil pediatric COVID-19 vaccinations at >27k sites, finding key differences in uptake & spatial accessibility by race, rurality, and social vulnerability. #Pharmacoequity #PedsTwitter publications.aap.org/pediatrics/art…

Nice overview of our session at #ADSciSessions on #Pharmacoequity and antiobesity 💊. “A racial wealth gap also makes it difficult for patients to afford the costly 💊, with Black/Hispanic Americans having about 1% of the wealth White Americans have...” adameetingnews.org/session-addres…

NEW in The Associated Press. Spoke with Thalia Beaty about the historic new *$600 million* donation to 4 Black medical schools (Howard, Meharry, Charles Drew, and Xavier University) and what it means for the diversity of the workforce and most importantly for #HealthEquity. apnews.com/article/mike-b…

New pub in JAMA Internal Medicine with Utibe R. Essien, MD MPH #Deprescribing involves identifying & discontinuing meds where potential harms outweigh benefits. It’s crucial for older adults, particularly those w/ afib, to receive safe, effective & tailored med regimens tinyurl.com/bdf826n6 1/8

Ever heard of #Deprescribing Equity? Great read from Utibe R. Essien, MD MPH & Michelle S. Keller, PhD in JAMA Internal Medicine: buff.ly/3YJM6XK Let's ensure #deprescribing access for all. Find more tools on how to engage stakeholders in shared-decision making here: buff.ly/416wOM9

Ensuring appropriate prescribing for older adults with AF and other common chronic conditions is a public health imperative. Utibe R. Essien, MD MPH and @MichelleSKeller provide a new #deprescribing equity framework to bring us closer to achieving this goal. ja.ma/3yFwbz9

Thank you for sharing our work CADeN! #DeprescribingEquity

Addressing treatment gaps and enhancing care for all are crucial in healthcare implementation. What can we learn from the VA system🤔? Utibe R. Essien, MD MPH w fascinating data at #ESCCongress showing mortality disparities in pts w afib appear to be mitigated in this system. #ESCCongress2024

Grateful for the opportunity to share some of our latest work at #ESCCongress in 🇬🇧. #AFib #HealthEquity 📸: Taher Modarressi, M.D.

New pub: Our latest findings reveal that Latino caregivers of dementia patients often turn to community support, as the healthcare system falls short in managing behavioral symptoms. #DementiaAwareness #Caregiving link.springer.com/content/pdf/10…

“Among patients with #AFib at risk for stroke, treatment w. asundexian (Factor XIa inhibitor) was associated with a ⬆️ incidence of stroke or systemic embolism than treatment with apixaban… before the trial was stopped prematurely.” 😬 nejm.org/doi/full/10.10…